152 related articles for article (PubMed ID: 38758091)
1. Electrocardiographic risk stratification in patients with a primary prophylactic implantable cardioverter defibrillator: can future arrhythmias correlating with sudden cardiac death be predicted?
Zabel M; Friede T
Europace; 2024 Jun; 26(6):. PubMed ID: 38758091
[TBL] [Abstract][Full Text] [Related]
2. Lack of Prognostic Value of T-Wave Alternans for Implantable Cardioverter-Defibrillator Benefit in Primary Prevention.
Pelli A; Kenttä TV; Junttila MJ; Huber C; Schlögl S; Zabel M; Malik M; Willems R; Vos MA; Harden M; Friede T; Sticherling C; Huikuri HV;
J Am Heart Assoc; 2024 Jun; 13(11):e032465. PubMed ID: 38804218
[TBL] [Abstract][Full Text] [Related]
3. Prospective observational study of implantable cardioverter-defibrillators in primary prevention of sudden cardiac death: study design and cohort description.
Cheng A; Dalal D; Butcher B; Norgard S; Zhang Y; Dickfeld T; Eldadah ZA; Ellenbogen KA; Guallar E; Tomaselli GF
J Am Heart Assoc; 2013 Feb; 2(1):e000083. PubMed ID: 23525420
[TBL] [Abstract][Full Text] [Related]
4. Ongoing Risk of Ventricular Arrhythmias and All-Cause Mortality at Implantable Cardioverter Defibrillator Generator Change: A Systematic Review and Meta-Analysis.
Yuyun MF; Erqou SA; Peralta AO; Hoffmeister PS; Yarmohammadi H; Echouffo-Tcheugui JB; Martin DT; Joseph J; Singh JP
Circ Arrhythm Electrophysiol; 2021 Mar; 14(3):e009139. PubMed ID: 33554611
[TBL] [Abstract][Full Text] [Related]
5. Implantable Cardioverter Defibrillator Lead Survival in Athletic Patients.
Link MS; Sullivan RM; Olshansky B; Cannom D; Berul CI; Hauser RG; Heidbuchel H; Jordaens L; Krahn AD; Morgan J; Patton KK; Saarel EV; Wilkoff BL; Li F; Dziura J; Brandt C; Barth C; Lampert R
Circ Arrhythm Electrophysiol; 2021 Mar; 14(3):e009344. PubMed ID: 33724879
[No Abstract] [Full Text] [Related]
6. Implantable Defibrillator Timing Windows: When Coincidence Can Be Confusing.
Jackson N; Viswanathan K; Cameron D; Nair K
Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e002876. PubMed ID: 26902146
[No Abstract] [Full Text] [Related]
7. End-of-life of implantable defibrillator: are we certain it should always be replaced?
Stazi F
J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e116-e119. PubMed ID: 29538158
[No Abstract] [Full Text] [Related]
8. Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper.
Probst V; Boveda S; Sadoul N; Marquié C; Chauvin M; Mondoly P; Gras D; Jacon P; Defaye P; Leclercq C; Anselme F
Arch Cardiovasc Dis; 2020 May; 113(5):359-366. PubMed ID: 32334981
[TBL] [Abstract][Full Text] [Related]
9. Should an implanted defibrillator be considered in patients with vasospastic angina?
Eschalier R; Souteyrand G; Jean F; Roux A; Combaret N; Saludas Y; Clerfond G; Barber-Chamoux N; Citron B; Lusson JR; Brugada P; Motreff P
Arch Cardiovasc Dis; 2014 Jan; 107(1):42-7. PubMed ID: 24373622
[TBL] [Abstract][Full Text] [Related]
10. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention.
Muthalaly RG; Kwong RY; John RM; van der Geest RJ; Tao Q; Schaeffer B; Tanigawa S; Nakamura T; Kaneko K; Tedrow UB; Stevenson WG; Epstein LM; Kapur S; Zei PC; Koplan BA
JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1177-1184. PubMed ID: 30121262
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of gamma-glutamyltransferase for ventricular arrhythmias and cardiovascular mortality in implantable cardioverter-defibrillator patients.
Zhou Y; Zhao S; Chen K; Hua W; Zhang S
BMC Cardiovasc Disord; 2019 May; 19(1):129. PubMed ID: 31146684
[TBL] [Abstract][Full Text] [Related]
12. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
[TBL] [Abstract][Full Text] [Related]
13. Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long-Term Follow-Up.
Rudic B; Tülümen E; Berlin V; Röger S; Stach K; Liebe V; El-Battrawy I; Dösch C; Papavassiliu T; Akin I; Borggrefe M; Kuschyk J
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042423
[TBL] [Abstract][Full Text] [Related]
14. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
Priori SG; Blomström-Lundqvist C; Mazzanti A; Blom N; Borggrefe M; Camm J; Elliott PM; Fitzsimons D; Hatala R; Hindricks G; Kirchhof P; Kjeldsen K; Kuck KH; Hernandez-Madrid A; Nikolaou N; Norekvål TM; Spaulding C; Van Veldhuisen DJ;
Europace; 2015 Nov; 17(11):1601-87. PubMed ID: 26318695
[No Abstract] [Full Text] [Related]
15. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
[TBL] [Abstract][Full Text] [Related]
16. Baroreflex sensitivity assessed with the sequence method is associated with ventricular arrhythmias in patients implanted with a defibrillator for the primary prevention of sudden cardiac death.
Garcia R; Degand B; Fraty M; Le Marcis V; Bidegain N; Laude D; Tavernier M; Le Gal F; Hadjadj S; Saulnier PJ; Ragot S
Arch Cardiovasc Dis; 2019 Apr; 112(4):270-277. PubMed ID: 30670362
[TBL] [Abstract][Full Text] [Related]
17. The wearable cardioverter-defibrillator: current technology and evolving indications.
Reek S; Burri H; Roberts PR; Perings C; Epstein AE; Klein HU; ; Lip G; Gorenek B; Sticherling C; Fauchier L; Goette A; Jung W; Vos MA; Brignole M; Elsner C; Dan GA; Marin F; Boriani G; Lane D; Blomström-Lundqvist C; Savelieva I
Europace; 2017 Mar; 19(3):335-345. PubMed ID: 27702851
[TBL] [Abstract][Full Text] [Related]
18. The implantable cardioverter-defibrillator: An update.
Miller JD; Yousuf O; Berger RD
Trends Cardiovasc Med; 2015 Oct; 25(7):606-11. PubMed ID: 25912255
[TBL] [Abstract][Full Text] [Related]
19. Prevention of Sudden Cardiac Death: Focus on the Subcutaneous Implantable Cardioverter-Defibrillator.
Adduci C; Palano F; Silvetti G; Cosentino P; Francia P
High Blood Press Cardiovasc Prev; 2020 Aug; 27(4):291-297. PubMed ID: 32519207
[TBL] [Abstract][Full Text] [Related]
20. Arrhythmogenic Cardiomyopathy.
Corrado D; Basso C; Judge DP
Circ Res; 2017 Sep; 121(7):784-802. PubMed ID: 28912183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]